New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile. [electronic resource]
- Journal of medicinal chemistry Jun 2014
- 4487-97 p. digital
Publication Type: Journal Article; Review
1520-4804
10.1021/jm401931e doi
Acetamides--adverse effects Animals Anti-Bacterial Agents--adverse effects Bone Marrow Cells--cytology Clinical Trials, Phase I as Topic Drug Design Drug Resistance, Bacterial Gram-Positive Bacteria--drug effects Gram-Positive Bacterial Infections--drug therapy Humans Linezolid Monoamine Oxidase Inhibitors--chemistry Oxazolidinones--adverse effects Pyridones--adverse effects Sepsis--drug therapy